We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $268M
1-Year Est. Return 158.98%
This Fund
S&P 500
This Quarter Est. Return
+39.3%
1 Year Est. Return
+158.98%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$223M
AUM Growth
+$77.2M
Cap. Flow
+$48M
Cap. Flow %
21.55%
Top 10 Hldgs %
25.3%
Holding
464
New
223
Increased
67
Reduced
60
Closed
103

Top Buys

Rank Stock Value
1
MOH icon
Molina Healthcare
MOH
+$8.43M
2
ELV icon
Elevance Health
ELV
+$5.15M
3
INTC icon
Intel
INTC
+$4.26M
4
SNDK
Sandisk
SNDK
+$3.61M
5
JNJ icon
Johnson & Johnson
JNJ
+$3.5M

Top Sells

Rank Stock Value
1
IEF icon
iShares 7-10 Year Treasury Bond ETF
IEF
+$4.82M
2
UNH icon
UnitedHealth
UNH
+$3.15M
3
IBIT icon
iShares Bitcoin Trust
IBIT
+$2.87M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.84M
5
LH icon
Labcorp
LH
+$2.58M

Sector Composition

Rank Sector Weight
1 Healthcare 52.36%
2 Technology 13.57%
3 Financials 11.27%
4 Communication Services 4.48%
5 Energy 3.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLS icon
301
CALL
SELLAS Life Sciences
SLS
$2.59B
$37.2K 0.02%
1,145
+225
+24% +$437
CLYM
302
Climb Bio
CLYM
$727M
$36.9K 0.02%
9,228
-18,993
-67% -$45.6K
XNTK icon
303
PUT
State Street SPDR NYSE Technology ETF
XNTK
$2.05B
$36.2K 0.02%
+669
New +$187K
EOLS icon
304
CALL
Evolus
EOLS
$377M
$32.6K 0.01%
+318
New +$2.15K
XBIT icon
305
XBiotech
XBIT
$69.2M
$32.4K 0.01%
+13,565
New +$33.4K
MLTX icon
306
CALL
MoonLake Immunotherapeutics
MLTX
$1.64B
$30.3K 0.01%
126
+65
+107% +$767
PRTC
307
DELISTED
PureTech Health
PRTC
$29.4K 0.01%
1,759
+74
+4% +$1.27K
INBX icon
308
Inhibrx
INBX
$1.28B
$27.3K 0.01%
+346
New +$23.6K
JANX icon
309
CALL
Janux Therapeutics
JANX
$992M
$26K 0.01%
+80
New +$1.88K
ROIV icon
310
PUT
Roivant Sciences
ROIV
$24.8B
$25.8K 0.01%
860
+169
+24% +$3.33K
TGTX icon
311
PUT
TG Therapeutics
TGTX
$8.4B
$24.2K 0.01%
+265
New +$8.65K
VIR icon
312
CALL
Vir Biotechnology
VIR
$1.59B
$20.9K 0.01%
+238
New +$1.42K
INSM icon
313
CALL
Insmed
INSM
$23.5B
$20.3K 0.01%
+142
New +$25.9K
BIOA
314
CALL
BioAge Labs
BIOA
$1.01B
$20.3K 0.01%
+61
New +$541
MELI icon
315
Mercado Libre
MELI
$92B
$20.1K 0.01%
+10
New +$21K
VTGN icon
316
VistaGen Therapeutics
VTGN
$9.4M
$17.6K 0.01%
26,612
-48,707
-65% -$176K
EDSA icon
317
Edesa Biotech
EDSA
$63.6M
$17.5K 0.01%
+12,319
New +$24.1K
LYEL icon
318
PUT
Lyell Immunopharma
LYEL
$326M
$16.3K 0.01%
+10
New +$224
PRAX icon
319
PUT
Praxis Precision Medicines
PRAX
$8.77B
$15.6K 0.01%
230
– –
CNTA
320
CALL
DELISTED
Centessa Pharmaceuticals
CNTA
$15.5K 0.01%
+57
New +$1.44K
BDTX icon
321
CALL
Black Diamond Therapeutics
BDTX
$103M
$13.1K 0.01%
+512
New +$1.81K
TVTX icon
322
PUT
Travere Therapeutics
TVTX
$5.27B
$13.1K 0.01%
134
+133
+13,300% +$4.33K
CRSP icon
323
CALL
CRISPR Therapeutics
CRSP
$4.71B
$10.8K ﹤0.01%
258
– –
PNTG icon
324
Pennant Group
PNTG
$1.46B
$10K ﹤0.01%
356
-76,055
-100% -$2.02M
JBIO
325
PUT
Jade Biosciences
JBIO
$1.27B
$8.95K ﹤0.01%
88
– –
11 12
13
14 15

Similar funds

VC
VarCov Co Darien, Connecticut $268M AUM
AL
AIP LLC New York $268M AUM 40.4% 1-Year Est. Return
FC
Foursixthree Capital New York $268M AUM 115.24% 1-Year Est. Return
NF
Nvest Financial Portsmouth, New Hampshire $268M AUM 22.87% 1-Year Est. Return
PF
Prosperitas Financial Valencia, California $268M AUM 32.64% 1-Year Est. Return
UI
Untitled Investments New York $269M AUM 11.35% 1-Year Est. Return
SSWM
Strait & Sound Wealth Management San Francisco, California $269M AUM 22.03% 1-Year Est. Return
AC
Applied Capital Little Rock, Arkansas $268M AUM 16.92% 1-Year Est. Return

Persistent Asset Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Persistent Asset Partners held 464 positions worth $223M, up 53% from $145M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Persistent Asset Partners deployed $48M of net new capital in Q4 2025, opening 223 new positions and adding to 67 existing holdings. Its largest new stake was Molina Healthcare: 51,285 shares worth $8.9M.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 49% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was UnitedHealth, an estimated $3.15M trimmed.

  • Persistent Asset Partners's largest Q4 2025 buy was Molina Healthcare: 51,285 shares worth $8.9M.
  • Persistent Asset Partners added most to Elevance Health in Q4 2025, an estimated $5.15M increase.
  • Persistent Asset Partners's biggest Q4 2025 reduction was UnitedHealth, cutting an estimated $3.15M.
  • Persistent Asset Partners fully exited iShares 7-10 Year Treasury Bond ETF in Q4 2025, selling an estimated $4.82M.
  • Persistent Asset Partners's ten largest holdings make up 25% of its $223M portfolio in Q4 2025.
  • Persistent Asset Partners opened 223 new positions and closed 103 in Q4 2025.
  • Persistent Asset Partners's portfolio value rose 53% quarter-over-quarter to $223M.

Based on Persistent Asset Partners's 13F filing for Q4 2025, filed 17 Feb 2026.